Occult hepatitis B virus and hepatitis C virus infections

Reviews in Medical Virology - Tập 18 Số 3 - Trang 139-157 - 2008
V. Carreño1, Javier Bartolomé1, Inmaculada Castillo1, Juan Antonio Quiroga1
1Fundación para el Estudio de las Hepatitis Virales, Madrid, Spain

Tóm tắt

AbstractOccult HBV infection is a well‐recognised clinical entity characterised by the detection of HBV‐DNA in serum and/or in liver in the absence of detectable hepatitis B surface antigen (HBsAg). Occult HBV infection has been described not only in patients who have resolved an acute or chronic HBV infection but also in patients without any serological markers of a past HBV infection. Occult HBV infection in patients with chronic HCV infection may induce more severe liver disease and lower response rate to interferon treatment. The existence of occult HCV infections has been also reported more recently. Occult HCV infection is characterised by the presence of HCV‐RNA in liver and peripheral blood mononuclear cells in the absence of detectable serum HCV‐RNA. Occult HCV infection may occur under two different clinical situations: in hepatitis C antibody‐(anti‐HCV) negative and serum HCV‐RNA‐negative patients with abnormal liver function tests and in anti‐HCV‐positive patients who have no detectable serum HCV‐RNA and who have normal liver enzymes. The clinical relevance of occult HCV infections is still under investigation. Copyright © 2008 John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

10.1038/317489a0

10.1128/JVI.14.2.384-391.1974

Magnius LO, 1975, A new antigen‐antibody system. Clinical significance in long‐term carriers of hepatitis B surface antigen, J Am Med Assoc, 231, 356, 10.1001/jama.1975.03240160020020

10.1016/0092-8674(82)90157-X

10.1128/CMR.5.3.275

10.1056/NEJM199712113372406

10.7326/0003-4819-115-2-113

10.1056/NEJM197806222982502

10.1111/j.1600-0676.1990.tb00429.x

10.1172/JCI116950

Cabrerizo M, 1997, Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen‐negative hemodialysis patients and staff, J Am Soc Nephrol, 8, 1143, 10.1681/ASN.V891443

10.1002/hep.510270526

10.1002/hep.510270638

Di Bisceglie AM, 1995, Long‐term outcome of interferon‐alpha therapy for chronic hepatitis B, J Hepatol, 22, 65

10.1111/j.1365-2893.1997.tb00157.x

10.1016/S0168-8278(05)80407-6

10.1053/jhep.2000.8541

10.1007/978-4-431-68255-4_197

10.1002/jmv.10514

10.1111/j.1365-2893.2004.00502.x

10.1053/j.gastro.2003.10.048

10.1002/jmv.1890450210

10.1056/NEJM199907013410104

10.1002/(SICI)1096-9071(199907)58:3<201::AID-JMV3>3.0.CO;2-2

10.1128/JCM.40.11.4068-4071.2002

10.1111/j.1365-2893.2004.00513.x

Oguchi H, 1992, Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units, Clin Nephrol, 38, 36

10.1016/S0168-8278(02)00457-9

10.1002/jmv.20075

10.1002/hep.20025

10.1002/jmv.20985

10.1002/hep.510290329

10.1002/jmv.10432

10.1002/hep.510310235

10.1002/jmv.20073

10.1016/S0168-8278(00)80134-8

10.1002/hep.510250141

10.1002/hep.1840180605

10.1056/NEJM199007123230202

10.1016/0016-5085(92)91523-7

10.1002/hep.1840170106

10.1016/S0168-8278(98)80001-9

10.1002/hep.1840090321

10.1002/cncr.21702

10.1002/1097-0142(19920601)69:11<2731::AID-CNCR2820691117>3.0.CO;2-9

10.1002/(SICI)1097-0215(19990209)80:4<497::AID-IJC3>3.0.CO;2-8

10.1002/hep.1840130607

10.1136/gut.47.3.429

10.1016/S0168-8278(00)00100-8

10.1007/BF02063934

10.1002/(SICI)1096-9071(199708)52:4<399::AID-JMV10>3.0.CO;2-C

10.1007/s007050050099

10.1016/S0168-8278(00)80311-6

10.1002/jmv.20943

Ferraro D, 2003, Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C, J Biol Regul Homeost Agents, 17, 172

10.1016/S1386-6532(03)00117-3

10.1016/0016-5085(91)90599-G

10.1016/0016-5085(91)70034-U

10.1126/science.284.5415.825

10.1146/annurev.immunol.19.1.65

10.1128/JVI.68.4.2671-2676.1994

Hou J, 1995, A unique insertion in the S gene of surface antigen‐negative hepatitis B virus Chinese carriers, Hepatology, 21, 273

10.1053/jhep.2002.32710

10.1053/j.gastro.2004.08.003

10.1002/hep.21529

10.1007/BF01644957

10.1093/infdis/165.5.831

10.1128/JVI.67.10.5823-5832.1993

10.1016/S0168-8278(02)00296-9

10.1074/jbc.M204241200

10.1006/viro.2002.1701

10.1128/JVI.79.24.15578-15581.2005

10.1016/S1473-3099(02)00345-6

10.3748/wjg.v13.i43.5682

10.1038/nm1096-1104

10.1038/nri1573

10.1172/JCI118902

10.1084/jem.191.8.1269

10.1146/annurev.iy.13.040195.000333

Koziel MJ, 2005, Cellular immune responses against hepatitis C virus, Clin Infect Dis, 41, S25, 10.1086/429492

10.1002/hep.20332

10.1002/hep.20614

Bartendchlager R, 2000, Replication of hepatitis C virus, J GenVirol, 81, 1631

10.1002/hep.20119

10.1002/hep.510270632

10.1086/380202

10.1136/gut.2004.057281

10.1086/504692

10.3844/ajidsp.2005.34.42

10.1086/429834

10.1128/JVI.78.11.5867-5874.2004

10.1002/hep.20518

10.1086/508198

10.1086/432917

10.1016/j.jcv.2004.08.005

10.1128/JVI.02750-06

10.1111/j.1365-2893.2006.00783.x

10.2169/internalmedicine.43.279

10.1136/jcp.2005.033050

10.1053/jhep.2000.19288

10.1016/S0168-8278(03)00470-7

10.1002/jmv.20784

10.1016/S0016-5085(99)70237-4

10.1086/428128

10.1038/75063

10.1136/gut.50.5.693

10.1111/j.1537-2995.2004.00656.x

10.1186/1743-422X-4-58

10.1086/421282

10.4269/ajtmh.2005.73.1.0730044

10.1002/jmv.20124

10.1016/S0042-6822(03)00461-6

10.1086/511038

10.1073/pnas.0402458101

10.1073/pnas.0403519101

10.1128/JCM.43.8.3877-3883.2005

10.1128/JCM.01440-06

10.1086/383279

10.1002/jmv.20846

10.1016/0140-6736(90)93101-T

10.1128/CVI.00128-07

10.1002/jmv.20864

10.1146/annurev.immunol.25.022106.141602

10.1016/S0140-6736(05)70197-5

10.1086/516546

Scognamiglio P, 1999, Presence of effector CD8+1; T cells in hepatitis C virus‐exposed healthy seronegative donors, J Immunol, 162, 6681, 10.4049/jimmunol.162.11.6681

10.1128/JVI.78.22.12252-12258.2004

10.1002/eji.200424889

10.1086/422605

10.1128/JVI.00852-06

10.1053/j.gastro.2006.11.044

10.1136/gut.44.3.424

10.1084/jem.191.9.1499

10.1016/S0168-8278(04)00052-2

10.1002/jmv.20680

10.1023/A:1007455509185

10.1023/A:1007459626023

10.1016/S0168-8278(96)80063-8

10.1046/j.1365-2893.2000.00203.x

10.1111/j.1365-2036.2006.02886.x

Thông tin
Thông tin xuất bản

Reviews in Medical Virology

Tập 18 Số 3

139-157

Thông tin tác giả